Akèy › Maladi poumon entèstisyèl › Kansas › Kansas City
Etid klinik pou Maladi poumon entèstisyèl nan Kansas City, KS
13 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan ak bò kote Kansas City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
Ap rekriteFaz 3
- University of Kansas Medical Center, Kansas City
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
Ap rekriteFaz 3
- University of Kansas Medical Center, Kansas City
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteFaz 3
- USA002, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Ap rekriteFaz 2
- University of Kansas Medical Center, Kansas City
A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD
Ap rekriteFaz 2
- Clinical Research Site, Kansas City
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Ap rekriteEtid obsèvasyon
- University of Kansas Medical Center, Kansas City
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- University of Kansas School of Medicine, Kansas City
RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
Ap rekriteFaz 2/3
- University of Kansas Medical Center, Kansas City
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
Ap rekriteFaz 2
- The University of Kansas Medical Center Research Institute, Kansas City
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Ap rekriteFaz 3
- University of Kansas Medical Center, Kansas City
Interstitial Lung Disease Research Unit Biobank
Ap rekriteEtid obsèvasyon
- The University of Kansas Medical Center, Kansas City
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
Ap rekriteFaz 1Volontè an sante akeyi
- University of Kansas Medical Center, Kansas City
Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease
Ap rekriteEtid obsèvasyon
- University of Kansas, Kansas City
Etid Maladi poumon entèstisyèl nan lòt vil
- New York City, NY18 etid
- Philadelphia, PA16 etid
- Los Angeles, CA14 etid
- Charleston, SC13 etid
- Durham, NC13 etid
- Chicago, IL12 etid
- Houston, TX12 etid
- Aurora, CO11 etid
- Ann Arbor, MI11 etid
- Salt Lake City, UT9 etid
- Dallas, TX9 etid
- Boston, MA9 etid
Lòt etid nan Kansas City
- Maladi kadyovaskilè14 etid
- Ensifizyans kadyak13 etid
- Obèsite13 etid
- Fibroz sistik13 etid
- Kansè nan tete12 etid
- Kansè vejik12 etid
- Leksemi mieloïd egi12 etid
- Kansè pwostat12 etid
- Kansè Poumon ki pa ti selil11 etid
- Kansè poumon11 etid
- BPCO9 etid
- Asm8 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.